Download video

Major breakthrough in cancer treatment

No views

NBC News

2 days ago

Major breakthrough in cancer treatment

Major breakthrough in cancer treatment

Pancreatic Cancer WARNING Signs You Shouldn't Ignore
11:02
Pancreatic Cancer WARNING Signs You Shouldn't Ignore
by Men’s Health Rise
HER2 Positive Breast Cancer: What You Need to Know
8:52
HER2 Positive Breast Cancer: What You Need to Know
by Cancer Treatment Updates
Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer
45:42
Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer
by Research To Practice
BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBC
4:07
BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBC
by ecancer
Precision medicine in cancer: A new era
23:24
Precision medicine in cancer: A new era
by J\&J Innovative Medicine EMEA\
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
1:11
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
by VJOncology
Metastatic HR+\/HER2- Breast Cancer Case | CDK4\/6 Inhibitors, CNS Progression \& Treatment Strategies
58:03
Metastatic HR+\/HER2- Breast Cancer Case | CDK4\/6 Inhibitors, CNS Progression \& Treatment Strategies
by American Board Certified Doctors for Egypt
Pt 3 New KRAS Lung Cancer Trials Could Change Everything: What’s Coming Next- Dr Negrao, MD ANDERSON
23:12
Pt 3 New KRAS Lung Cancer Trials Could Change Everything: What’s Coming Next- Dr Negrao, MD ANDERSON
by Young Lung Cancer Initiative
The Top 5 Best Chlorophyll Supplements in 2025 - Must Watch Before Buying!
9:29
The Top 5 Best Chlorophyll Supplements in 2025 - Must Watch Before Buying!
by Top Best Picks
The Top 5 Best Chlorophyll in 2025 - Must Watch Before Buying!
9:39
The Top 5 Best Chlorophyll in 2025 - Must Watch Before Buying!
by Top Best Picks
Game-changing Advances in Cancer Treatment
2:47
Game-changing Advances in Cancer Treatment
by OncologyTube
CDK4\/6 inhibitor switching in HR+\/HER2- metastatic breast cancer
0:48
CDK4\/6 inhibitor switching in HR+\/HER2- metastatic breast cancer
by VJOncology
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
5:30
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
by OncologyTube
The Future of Cancer Treatment: 63% pCR Rate with Nivolumab Relatlimab
6:03
The Future of Cancer Treatment: 63% pCR Rate with Nivolumab Relatlimab
by OncologyTube
Efficacy of trastuzumab deruxtecan in HER2-low metastatic breast cancer
1:05
Efficacy of trastuzumab deruxtecan in HER2-low metastatic breast cancer
by VJOncology
Cancer cure research. NEW 5-Minute Cancer Jab Fights 15 Types! NHS has launched
2:08
Cancer cure research. NEW 5-Minute Cancer Jab Fights 15 Types! NHS has launched
by MedTalks with Dr. kayode (ZOOM HOSPITAL)
MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research \& Treatment Landscape
1:00:45
MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research \& Treatment Landscape
by Susan G. Komen®
Therapeutic strategies to overcome HER2 resistance in gastric cancer
1:35
Therapeutic strategies to overcome HER2 resistance in gastric cancer
by VJOncology
Cancer and the Immune System Part 2: Vaccines and Immunotherapy - 2025 Lung Cancer Video Library
5:17
Cancer and the Immune System Part 2: Vaccines and Immunotherapy - 2025 Lung Cancer Video Library
by Global Resource for Advancing Cancer Education
Pt 2 KRAS Lung Cancer Treatment Explained: Options, Co-Mutations \& New Hope with Dr. Marcelo Negrao
14:28
Pt 2 KRAS Lung Cancer Treatment Explained: Options, Co-Mutations \& New Hope with Dr. Marcelo Negrao
by Young Lung Cancer Initiative
Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53
1:34
Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53
by VJOncology
RETAIN-2: risk enabled therapy after neoadjuvant chemo-IO in MIBC
1:33
RETAIN-2: risk enabled therapy after neoadjuvant chemo-IO in MIBC
by VJOncology
2B | A MyCancerHaven™ Expert Roundtable:The Evolution of MM: Selecting Treatment After 3rd Relapse
28:28
2B | A MyCancerHaven™ Expert Roundtable:The Evolution of MM: Selecting Treatment After 3rd Relapse
by MyCancerHaven for Patients \& Caregivers